Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma

NCT02319889 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Funding unavailable

Conditions

Stage I Non-Small Cell Lung Cancer
Stage II Non-Small Cell Lung Cancer

Interventions

RADIATION: Stereotactic Body Radiotherapy
DRUG: Carboplatin
DRUG: Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]